China Healthcare Summit
November 2-3, 2023 | Shanghai

November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.

---

Written by Richard Daverman, PhD. Click a link below to view the mailing archive as if it had been sent to you. 2013-03-31 01:30 Week in Review: Sinopharm Building M&A War Chest 2013-03-30 01:30 Agenix to File for Clinical Trial of Hepatitis B Drug by June and more... 2013-03-29 01:30 SK Biopharma Partners with China Companies on Novel CNS Drug and more... 2013-03-28 01:30 China's MOH Issues New Essential Drug List with 520 Products 2013-03-27 01:30 Weihai Weigao to Distribute TriReme's Cardiology Devices in China 2013-03-26 01:30 Cellular Biomedicine Starts China Trial of Liver Cancer Treatment and more... 2013-03-24 01:30 Week in Review: BGI's CEO Says Science Drives Collaborations 2013-03-23 01:30 OriGene Raises $21.3 Million from China Investors and more... 2013-03-22 01:30 Hony Capital Backs Simcere's Privatization Bid and more... 2013-03-21 01:30 Roche May Make a Bid for Life Technologies and more... 2013-03-20 01:30 Dream Driven: Exclusive Interview with Dr. Jun Wang, Executive Director of BGI and more... 2013-03-19 01:30 Taiwan Liposome's Liver Cancer Drug Put on Fast Track in China 2013-03-17 01:30 Week in Review: Simcere Receives $503 Million Privatization Offer 2013-03-16 01:30 Shanghai BravoBio Named BioSpectrum Emerging Company of the Year and more... 2013-03-15 01:30 Sinovac Biotech's Hand, Foot and Mouth Vaccine Succeeds in Phase III Trial 2013-03-14 01:30 Domain and Elite Team Up to Bring Life Science Products to China and more... 2013-03-13 01:30 SFDA to Monitor Food Safety; Will Remain Part of MOH 2013-03-12 01:30 Simcere Pharma Receives $503 Million Buyout Offer from Chairman and more... 2013-03-10 01:30 The Week in Review: Sinopharm to Raise $640 Million through Bond Sale 2013-03-09 01:30 WuXi PharmaTech Reports $500 Million in 2012 Revenues and more... 2013-03-08 01:30 Sinopharm to Raise $640 Million in Bond Offering; Is M&A the Goal? 2013-03-07 01:30 China National Biotec and Riboxx Set Up Research Collaboration and more... 2013-03-06 01:30 Viva Biotech of Shanghai Forms Drug Discovery Partnership with Addex and more... 2013-03-05 01:30 Fosun Pharma Buys $22.4 Million of Saladax Stock and more... 2013-03-03 01:30 Week in Review: Sinopharm Pays $252 Million for Majority Stake in Winteam Pharma 2013-03-02 01:30 SFDA Proposes Further Reforms in China's Drug Approval Process and more... 2013-03-01 01:30 Polaris Group of San Diego to Build $50 Million Facility in Chengdu and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz Not a ChinaBio®Today Subscriber? Here's what you get with a paid subscription to ChinaBio® Today: Website access to all current articles and commentary Full access to over 2000 archived articles on the biotech industry Get started now for as little as $20... ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC